These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 6916710)

  • 1. The activation of the alternative pathway C3 convertase by human plasma kallikrein.
    DiScipio RG
    Immunology; 1982 Mar; 45(3):587-95. PubMed ID: 6916710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of factor B of the complement system by kallikrein and its light chain.
    Hiemstra PS; Daha MR; Bouma BN
    Thromb Res; 1985 Jun; 38(5):491-503. PubMed ID: 3848216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between the alternative complement pathway and proteases of the coagulation system.
    Kazatchkine MD; Jouvin MH
    Adv Exp Med Biol; 1984; 167():235-9. PubMed ID: 6561912
    [No Abstract]   [Full Text] [Related]  

  • 4. Kallikrein Cleaves C3 and Activates Complement.
    Irmscher S; Döring N; Halder LD; Jo EAH; Kopka I; Dunker C; Jacobsen ID; Luo S; Slevogt H; Lorkowski S; Beyersdorf N; Zipfel PF; Skerka C
    J Innate Immun; 2018; 10(2):94-105. PubMed ID: 29237166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
    Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
    Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alternative pathway C3/C5 convertase: chemical basis of factor B activation.
    Lesavre PH; Hugli TE; Esser AF; Müller-Eberhard HJ
    J Immunol; 1979 Aug; 123(2):529-34. PubMed ID: 458145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complement.
    Farries TC; Lachmann PJ; Harrison RA
    Biochem J; 1988 Aug; 253(3):667-75. PubMed ID: 3140783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuria.
    Parker CJ; Baker PJ; Rosse WF
    J Clin Invest; 1982 Feb; 69(2):337-46. PubMed ID: 6915939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the initial C3 convertase of the alternative pathway of human complement.
    Fishelson Z; Pangburn MK; Müller-Eberhard HJ
    J Immunol; 1984 Mar; 132(3):1430-4. PubMed ID: 6559201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the alternative C3 convertase and classical C5 convertase of complement by group A streptococcal M protein.
    Hong K; Kinoshita T; Takeda J; Kozono H; Pramoonjago P; Kim YU; Inoue K
    Infect Immun; 1990 Aug; 58(8):2535-41. PubMed ID: 2142480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A reexamination of the role of magnesium in the human alternative pathway of complement.
    Pryzdial EL; Isenman DE
    Mol Immunol; 1986 Jan; 23(1):87-96. PubMed ID: 3634188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanosoma lewisi: restriction of alternative complement pathway C3/C5 convertase activity.
    Sturtevant JE; Balber AE
    Exp Parasitol; 1987 Jun; 63(3):260-71. PubMed ID: 3556206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase.
    Pangburn MK; Müller-Eberhard HJ
    Biochem J; 1986 May; 235(3):723-30. PubMed ID: 3638964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3.
    Pangburn MK; Schreiber RD; Müller-Eberhard HJ
    J Exp Med; 1981 Sep; 154(3):856-67. PubMed ID: 6912277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The conversion of human complement component C5 into fragment C5b by the alternative-pathway C5 convertase.
    DiScipio RG
    Biochem J; 1981 Dec; 199(3):497-504. PubMed ID: 6918218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b,Bb.
    Fishelson Z; Müller-Eberhard HJ
    J Immunol; 1984 Mar; 132(3):1425-9. PubMed ID: 6229580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative complement pathway activation fragment Ba binds to C3b. Evidence that formation of the factor B-C3b complex involves two discrete points of contact.
    Pryzdial EL; Isenman DE
    J Biol Chem; 1987 Feb; 262(4):1519-25. PubMed ID: 3643213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C3/C5 convertase of the alternative pathway of complement: stabilization and restriction of control by lanthanide ions.
    Fishelson Z; Müller-Eberhard HJ
    Mol Immunol; 1983 Mar; 20(3):309-15. PubMed ID: 6553181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C3 convertase of the alternative complement pathway. Demonstration of an active, stable C3b, Bb (Ni) complex.
    Fishelson Z; Pangburn MK; Müller-Eberhard HJ
    J Biol Chem; 1983 Jun; 258(12):7411-5. PubMed ID: 6553050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activation of the C3b feedback cycle with human complement components. II. Using components of the alternative pathway.
    Mak LW; Majewski J; Lachmann PJ
    Clin Exp Immunol; 1977 Nov; 30(2):211-21. PubMed ID: 606443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.